A new, powerful Citizen Portal experience is ready. Switch now

Cost Transparency Board backs pre‑, post‑ and ongoing transaction review to monitor health care consolidation

July 22, 2026 | Board Council Commission Agencies , Executive, Washington


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Cost Transparency Board backs pre‑, post‑ and ongoing transaction review to monitor health care consolidation
The Cost Transparency Board on July 22 voted to include a recommendation in its 2026 legislative report to pursue a health care transaction review program that would operate before transactions close, after transactions conclude and as part of ongoing market monitoring.

Board members framed the action as a way to bring new state oversight tools to bear on hospital, insurer and private equity activity they said has contributed to higher prices and reduced local choice. "This could become continued extension of the board's work in 2027," staff said as they described next steps for stakeholder engagement and drafting. Emily Bryce moved the motion; Elois Cook seconded it. Chair Moran announced the motion passed with no recorded opposition.

Supporters described the recommendation as a directional step that will let staff and the legislature build the details later. Emily Bryce said the recommendation is "necessary but not sufficient," urging that pre‑transaction review be paired with ongoing market analysis and other cost‑containment tools. Several members stressed the need to include a broad set of entity types in any notice requirement, not only hospitals and traditional payers.

Opponents did not register on the record during the voice vote, but board members used the discussion to press for clarifications about timing and scope. Eileen Cody urged that the language make clear the review should occur before a merger closes: "it doesn't make it clear that we would like the review prior to a merger," she said. Staff committed to return with draft language and to solicit stakeholder input before finalizing the bill language.

The board's action follows two months of briefings — including presentations from Colorado and California officials — and public comment from trade groups and physician organizations who recommended Washington tailor approaches to its own data and legal context. Staff said the recommendation will be accompanied by a white paper describing options, tradeoffs and potential statutory language for the legislature to consider.

What happens next: staff will solicit additional stakeholder input in August and present detailed concepts to the board in September, then finalize the language for the 2026 legislative report.

View the Full Meeting & All Its Details

This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.

Watch full, unedited meeting videos
Search every word spoken in unlimited transcripts
AI summaries & real-time alerts (all government levels)
Permanent access to expanding government content
Access Full Meeting

30-day money-back guarantee